Harnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment

Area of Science:

• Oncology
• Stem Cell Biology
• Biomedical Engineering

Background:

• Cancer remains a leading global cause of death, with existing therapies facing efficacy limitations.
• Mesenchymal stem cells (MSCs) are multipotent stromal cells with tumor-targeting and immunomodulatory properties, making them attractive for cancer research.
• MSCs can differentiate into various cell types and are sourced from multiple tissues, including bone marrow and adipose tissue.

Purpose of the Study:

• To review the therapeutic potential of Mesenchymal stem cells (MSCs) in cancer treatment.
• To explore MSCs' homing properties, immunomodulatory effects, and use as drug delivery vehicles.
• To examine the role of MSCs and their exosomes in modulating cancer cell signaling pathways.

Main Methods:

• Literature review focusing on Mesenchymal stem cell (MSC) applications in oncology.
• Analysis of MSC characteristics, including tumor tropism, immunomodulation, and differentiation potential.
• Examination of MSC-derived exosomes as cell-free therapeutic agents.

Main Results:

• Mesenchymal stem cells (MSCs) exhibit significant tumor-homing capabilities and can be engineered as carriers for targeted delivery of anticancer agents.
• MSCs possess immunomodulatory functions that can be leveraged to enhance anti-tumor immune responses.
• MSCs can inhibit cancer progression by interfering with critical signaling pathways like wnt/β-catenin and PI3K/AKT/mTOR.

Conclusions:

• Mesenchymal stem cells (MSCs) and their exosomes represent a promising frontier in cancer therapy, offering novel mechanisms for treatment and drug delivery.
• Further research is needed to overcome challenges and fully realize the therapeutic potential of MSCs in clinical oncology.
• The unique properties of MSCs, including their ability to modulate signaling pathways and target tumors, underscore their significance in developing advanced cancer treatments.